Stock Events

Stock Events

Pasithea Therapeutics (KTTA) Q1 2026 Earnings

30MarConfirmed

Q2 2025

Q2 2025

Q4 2025

Q1 2026

-0.79

-0.59

-0.38

-0.18

Details

Expected EPS

-0.18

Actual EPS

-0.79

Surprise EPS

-0.61

Surprise Percent

+338.89%

Description

Pasithea Therapeutics (KTTA) has reported earnings of -0.79 per share for Q1 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.